T-LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo cocktail shows promise for rare blood cancers
Disease control Recruiting nowThis study tests a combination of several chemotherapy drugs plus nelarabine in people with untreated T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. The goal is to see how well this treatment works at stopping cancer growth and improving survival. About 160 partic…
Matched conditions: T-LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
Double-Targeted immune cells take on Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new type of CAR-T cell therapy that targets two different markers on cancer cells at the same time. It is for adults with blood cancers like leukemia, lymphoma, or multiple myeloma that have come back or not responded to other treatments. The goal is to se…
Matched conditions: T-LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 17, 2026 05:04 UTC